SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo US Bio-Tech informs about board meeting

13 Jul 2018 Evaluate

In terms of the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indo US Bio-Tech has informed that the Company will Publish audited yearly financial results of the Closure of the year ended on 31st March, 2018 and the Board meeting for approval of audited yearly Financial Result for the year ended on 31st March, 2018 will be held on 20th July, 2018 at 4.00 pm. at the registered office of the company.

The above information is a part of company’s filings submitted to BSE.

Indo US Bio-Tech Share Price

108.00 -1.43 (-1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1589.25
Mangalam Global Ent 12.93
Kaveri Seed 924.50
Regaal Resources 85.04
Simran Farms 165.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×